British Columbia Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.3M Buy
80,855
+6,641
+9% +$2.27M 0.18% 92
2026
Q1
$26.1M Sell
74,214
-21,316
-22% -$7.6M 0.15% 118
2025
Q4
$31.3M Buy
95,530
+18,163
+23% +$5.76M 0.16% 120
2025
Q3
$21.8M Sell
77,367
-7,339
-9% -$2.13M 0.13% 146
2025
Q2
$23.7M Sell
84,706
-18,096
-18% -$5.13M 0.14% 140
2025
Q1
$32M Sell
102,802
-89
-0.1% -$26.3K 0.2% 110
2024
Q4
$26.8M Buy
102,891
+13,385
+15% +$3.97M 0.16% 129
2024
Q3
$28.8M Sell
89,506
-13,143
-13% -$4.3M 0.17% 110
2024
Q2
$32.1M Buy
102,649
+38,537
+60% +$11.3M 0.19% 101
2024
Q1
$18.2M Buy
64,112
+2,537
+4% +$742K 0.13% 127
2023
Q4
$17.7M Buy
61,575
+12,988
+27% +$3.54M 0.14% 125
2023
Q3
$13.1M Buy
48,587
+319
+0.7% +$79.6K 0.12% 124
2023
Q2
$10.7M Buy
48,268
+566
+1% +$131K 0.1% 152
2023
Q1
$11.5M Buy
47,702
+268
+0.6% +$65.8K 0.12% 139
2022
Q4
$12.5M Sell
47,434
-5,503
-10% -$1.48M 0.14% 133
2022
Q3
$11.9M Sell
52,937
-11,730
-18% -$2.84M 0.13% 131
2022
Q2
$15.7M Sell
64,667
-22,392
-26% -$5.49M 0.15% 117
2022
Q1
$21.1M Sell
87,059
-12,773
-13% -$2.93M 0.13% 120
2021
Q4
$22.5M Sell
99,832
-6,417
-6% -$1.35M 0.13% 141
2021
Q3
$22.6M Sell
106,249
-588
-0.6% -$135K 0.13% 130
2021
Q2
$26M Buy
106,837
+11,189
+12% +$2.75M 0.16% 119
2021
Q1
$23.8M Sell
95,648
-3,428
-3% -$818K 0.17% 107
2020
Q4
$22.8M Sell
99,076
-3,005
-3% -$693K 0.16% 117
2020
Q3
$25.9M Buy
102,081
+7,491
+8% +$1.86M 0.21% 96
2020
Q2
$22.3M Buy
94,590
+29,536
+45% +$6.74M 0.22% 98
2020
Q1
$13.2M Sell
65,054
-76,459
-54% -$16.7M 0.22% 89
2019
Q4
$34.1M Sell
141,513
-15,981
-10% -$3.52M 0.25% 92
2019
Q3
$30.5M Sell
157,494
-41,713
-21% -$8.01M 0.3% 85
2019
Q2
$36.7M Buy
199,207
+1,124
+0.6% +$201K 0.32% 77
2019
Q1
$37.6M Sell
198,083
-54,680
-22% -$10.4M 0.34% 79
2018
Q4
$49.2M Buy
252,763
+13,614
+6% +$2.66M 0.44% 51
2018
Q3
$49.6M Sell
239,149
-89,537
-27% -$17.6M 0.52% 41
2018
Q2
$60.7M Sell
328,686
-116,664
-26% -$20.6M 0.54% 39
2018
Q1
$75.9M Sell
445,350
-59,583
-12% -$10.9M 0.58% 35
2017
Q4
$87.8M Buy
504,933
+25,237
+5% +$4.47M 0.62% 33
2017
Q3
$89.4M Sell
479,696
-2,495
-0.5% -$442K 0.69% 29
2017
Q2
$83M Sell
482,191
-14,941
-3% -$2.43M 0.66% 31
2017
Q1
$81.6M Buy
497,132
+88,989
+22% +$14.8M 0.65% 34
2016
Q4
$59.7M Buy
408,143
+30,792
+8% +$4.63M 0.52% 40
2016
Q3
$62.9M Sell
377,351
-51,247
-12% -$8.67M 0.63% 36
2016
Q2
$65.2M Buy
428,598
+4,080
+1% +$634K 0.57% 41
2016
Q1
$63.6M Buy
424,518
+2,850
+0.7% +$423K 0.6% 40
2015
Q4
$68.4M Buy
421,668
+18,397
+5% +$2.89M 0.66% 36
2015
Q3
$55.8M Sell
403,271
-807
-0.2% -$127K 0.57% 40
2015
Q2
$62M Sell
404,078
-86,845
-18% -$13.9M 0.59% 36
2015
Q1
$78.5M Sell
490,923
-85,444
-15% -$13.5M 0.71% 25
2014
Q4
$91.8M Sell
576,367
-7,213
-1% -$1.12M 0.76% 22
2014
Q3
$82M Sell
583,580
-21,899
-4% -$2.86M 0.69% 29
2014
Q2
$71.7M Sell
605,479
-3,884
-0.6% -$450K 0.58% 37
2014
Q1
$75.2M Sell
609,363
-48,267
-7% -$5.85M 0.63% 33
2013
Q4
$75M Buy
657,630
+43,033
+7% +$4.9M 0.59% 38
2013
Q3
$68.8M Sell
614,597
-58,449
-9% -$6.34M 0.58% 40
2013
Q2
$66.4M Buy
+673,046
New +$69.8M 0.55% 40

Other funds holding AMGN

British Columbia Investment Management's AMGN Position: Q2 2026 in Review

British Columbia Investment Management increased its Amgen (AMGN) stake by 8.9% in Q2 2026, buying an estimated $2.27M and bringing the position to 80,855 shares worth $29.3M. The position accounts for 0.18% of the portfolio, ranked #92.

British Columbia Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $91.8M in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • British Columbia Investment Management held 80,855 shares of Amgen worth $29.3M as of Q2 2026.
  • British Columbia Investment Management bought 6,641 Amgen shares in Q2 2026, an estimated $2.27M.
  • Amgen made up 0.18% of British Columbia Investment Management's portfolio in Q2 2026, its #92 holding.
  • British Columbia Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • British Columbia Investment Management's Amgen position peaked at $91.8M in Q4 2014.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.